Unchained Labs:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unchained Labs - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10987
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unchained Labs (Unchained) is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), freeslate and freeslate jr (automated workflow solution). Unchained Labs optim technology platform is developed for various applications such as stability studies, lead candidate selection and optimization, pre-formulation studies, candidate formulation among others. It markets its products to biopharmaceutical companies and academic institutions internationally throughout the world. The company’s venture capital is backed by investment firms such as Canaan Partners, TPG biotech, Novo Ventures. Unchained is headquartered in Pleasanton, California, the US.

Unchained Labs – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unchained Labs, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unchained Labs, Medical Devices Deals, 2012 to YTD 2018 8
Unchained Labs, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unchained Labs, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 10
Venture Financing 11
Unchained Labs Raises USD17 Million in Series D Financing 11
Unchained Labs Raises USD13 Million in Series C Financing 12
Unchained Labs Raises USD25 Million in Series B Financing 13
Unchained Labs Raises Additional USD6 Million in Series A Venture Financing 14
Unchained Labs Raises USD25 Million in Series A Financing 15
Trinean Raises US$5 Million In Venture Financing 16
Licensing Agreements 18
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 18
Acquisition 19
Unchained Labs Acquires Trinean 19
Unchained Labs Acquires Freeslate 20
Unchained Labs – Key Competitors 21
Unchained Labs – Key Employees 22
Unchained Labs – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Corporate Communications 25
Oct 24, 2017: Unchained Labs bulks up the Board, adds Max Carnecchia 25
Product News 26
Aug 21, 2017: Unchained Labs gets its quant on, launches Lunatic! 26
May 02, 2017: Unchained Labs rolls out Unfilter 27
Other Significant Developments 28
Sep 19, 2017: Unchained Labs makes automation workflows a cinch, releases LEA 9! 28
Mar 07, 2017: Unchained Labs turns UNcle up to 11 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Unchained Labs, Pharmaceuticals & Healthcare, Key Facts 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unchained Labs, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unchained Labs, Medical Devices Deals, 2012 to YTD 2018 8
Unchained Labs, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 10
Unchained Labs Raises USD17 Million in Series D Financing 11
Unchained Labs Raises USD13 Million in Series C Financing 12
Unchained Labs Raises USD25 Million in Series B Financing 13
Unchained Labs Raises Additional USD6 Million in Series A Venture Financing 14
Unchained Labs Raises USD25 Million in Series A Financing 15
Trinean Raises US$5 Million In Venture Financing 16
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 18
Unchained Labs Acquires Trinean 19
Unchained Labs Acquires Freeslate 20
Unchained Labs, Key Competitors 21
Unchained Labs, Key Employees 22
Unchained Labs, Other Locations 23
Unchained Labs, Subsidiaries 23

List of Figures
Unchained Labs, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unchained Labs, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unchained Labs, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Unchained Labs:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Konka Group Co., Ltd.
    Konka Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Konka Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Veridian Corporation:発電所・企業SWOT分析
    Veridian Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Toei Animation Co., Ltd. (4816):企業の財務・戦略的SWOT分析
    Toei Animation Co., Ltd. (4816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tsumura & Co.:企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AnaptysBio Inc (ANAB):製薬・医療:M&Aディール及び事業提携情報
    Summary AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody product candidates for the treatment of inflammatory, autoimmune and atopic diseases. The company develops its product candidates through its proprietary antibody discovery techn …
  • Universal Forest Products, Inc.:戦略・SWOT・企業財務分析
    Universal Forest Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Universal Forest Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • World Fuel Services Corp (INT):企業の財務・戦略的SWOT分析
    Summary World Fuel Services Corp (WFSC) is an oil and gas company that offers financial solutions and downstream marketing services. The company's services include oil and energy procurement, fuel management, lubricant analysis, energy management, LNG supply management, operation support, turnkey fu …
  • Setpoint Medical Inc-医療機器分野:企業M&A・提携分析
    Summary SetPoint Medical Inc. (SetPoint Medical) is a biotechnology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases. The company employs a scientific platform, which is based on inflammatory reflex. The company’s bioelectronic medicine platform und …
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Gold Fields Limited:企業のM&A・事業提携・投資動向
    Gold Fields Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gold Fields Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Public Bank Berhad:戦略・SWOT・企業財務分析
    Public Bank Berhad - Strategy, SWOT and Corporate Finance Report Summary Public Bank Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CaixaBank SA:戦略・SWOT・企業財務分析
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Livescribe Inc:企業の戦略的SWOT分析
    Livescribe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Merck & Co Inc (MRK):医療機器:M&Aディール及び事業提携情報
    Summary Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Zoetis Inc.:企業の戦略・SWOT・財務情報
    Zoetis Inc. - Strategy, SWOT and Corporate Finance Report Summary Zoetis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SMRT Corporation Ltd.:企業の戦略・SWOT・財務情報
    SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lietuvos Energija UAB:電力:M&Aディール及び事業提携情報
    Summary Lietuvos Energija UAB (Lietuvos Energija) is a state-owned utility. The utility’s activities include power and heat distribution and supply; natural gas trade and distribution; construction and maintenance of power plants and grid; development of energy infrastructure and green energy; and d …
  • Bisalloy Steel Group Ltd:企業の戦略・SWOT・財務分析
    Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆